In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.

MLA

Ganem, Nabeel S., et al. “In Cancer, A-to-I RNA Editing Can Be the Driver, the Passenger, or the Mechanic.” Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, vol. 32, May 2017, pp. 16–22. EBSCOhost, https://doi.org/10.1016/j.drup.2017.09.001.

APA

Ganem, N. S., Ben-Asher, N., & Lamm, A. T. (2017). In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 32, 16–22. https://doi.org/10.1016/j.drup.2017.09.001

Chicago

Ganem, Nabeel S, Noa Ben-Asher, and Ayelet T Lamm. 2017. “In Cancer, A-to-I RNA Editing Can Be the Driver, the Passenger, or the Mechanic.” Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 32 (May): 16–22. doi:10.1016/j.drup.2017.09.001.